ISB News

Register Now: ISB’s International Symposium

14th Annual International Symposium
April 6 and 7, 2015
Institute for Systems Biology

The Institute for Systems Biology’s Annual International Symposium, since its inception in 2002, has become a bellwether of new systems approaches across disciplines in the life sciences. The theme for 2015 is “Tipping Points in Medicine & Ecology” which is aligned with ISB’s focus on personalized medicine and environmental sustainability. The principles of critical phase transitions, early warning signs and, more generally, complex systems dynamics, offer a theoretical framework and analysis tools for understanding and predicting major state transitions in human health and in ecosystems. The Symposium aims to facilitate the translation of these theoretical principles to medicine and ecology. We hope you will join us for a lively exchange of ideas.

SEE LIST OF GUEST SPEAKERS

Recent Articles

  • Timing is Everything: ISB Study Finds Link Between Bowel Movement Frequency and Overall Health

    Everybody poops, but not every day. An ISB-led research team examined the clinical, lifestyle, and multi-omic data of more than 1,400 healthy adults. How often people poop, they found, can have a large influence on one’s physiology and health.

  • Wei Wei, PhD

    Dr. Wei Wei Promoted to Associate Professor

    Wei Wei, PhD – an accomplished cancer researcher with expertise in biotechnology and cancer systems biology – has been promoted to ISB associate professor. The Wei Lab focuses on understanding how cancer cells adapt to therapeutic treatment to foster therapy resistance by coordinating their internal molecular machinery and how these adaptive changes evolve within diverse tumors influenced by the tumor microenvironment. 

  • Drs. Nitin Baliga and James Park

    How Glioblastoma Resists Treatment – and Ways to Prevent It

    Glioblastoma is one of the deadliest and most aggressive forms of primary brain cancer in adults and is known for its ability to resist treatment and to recur. ISB researchers have made breakthrough discoveries in understanding the mechanisms behind acquired resistance, focusing on a rare and stubborn group of cells within tumors called glioma stem-like cells.